Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level

9. juli 2026 oppdatert av: Ankara Yildirim Beyazıt University
This randomized controlled experimental study was conducted to evaluate the effects of virtual reality glasses used during hemodialysis on patients' vital signs and anxiety levels. A total of 56 adult patients receiving hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital were randomly assigned to either an experimental group or a control group. Patients in the experimental group watched a 4K virtual reality nature video with relaxing background music during hemodialysis, while the control group received standard hemodialysis care. Vital signs, pain, anxiety, and satisfaction were assessed to evaluate the effectiveness of the virtual reality intervention.

Studieoversikt

Detaljert beskrivelse

The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.

The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).

Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.

Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.

Studietype

Intervensjonell

Registrering (Faktiske)

56

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Ankara, Tyrkia (Türkiye), 06200
        • Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Receiving hemodialysis treatment for the first time.
  • Age ≥18 years.
  • No visual, hearing, or cognitive impairment.
  • Able to communicate effectively.
  • Clinically stable.
  • No diagnosed psychiatric disorder or use of psychiatric medication.
  • No history of seizures.
  • Willing and able to provide informed consent.

Exclusion Criteria:

  • Previous hemodialysis treatment.
  • Age <18 years.
  • Visual, hearing, or cognitive impairment.
  • History of kidney transplantation.
  • Communication difficulties.
  • Diagnosed psychiatric disorder or use of psychiatric medication.
  • History of seizures.
  • Declined to participate in the study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes. The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
Aktiv komparator: Control Group
Participants received standard hemodialysis care without any additional intervention.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Systolic Blood Pressure
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in systolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Diastolic Blood Pressure
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in diastolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Heart Rate
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in heart rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Respiratory Rate
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in respiratory rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Peripheral Oxygen Saturation (SpO₂)
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Body Temperature
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in body temperature measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
State Anxiety Level After Hemodialysis
Tidsramme: Immediately after completion of the hemodialysis session.
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Pain Score
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain. Higher scores indicate greater pain. Pain was assessed before and immediately after completion of the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Participant Satisfaction Score
Tidsramme: Immediately after completion of the hemodialysis session.
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied. Higher scores indicate greater participant satisfaction. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: Hilal Tüzer, Assoc. Prof., Ankara Yildirim Beyazıt University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

3. mai 2023

Primær fullføring (Faktiske)

27. mai 2024

Studiet fullført (Faktiske)

27. mai 2024

Datoer for studieregistrering

Først innsendt

28. juni 2026

Først innsendt som oppfylte QC-kriteriene

9. juli 2026

Først lagt ut (Faktiske)

15. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

15. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. juli 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

IPD-planbeskrivelse

The decision regarding sharing of individual participant data has not yet been finalized. Any future data sharing will be considered in accordance with institutional policies, ethical requirements, and applicable regulations.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere